Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Heidelberg Pharma AG Director's Dealing 2010

Jul 23, 2010

201_dirs_2010-07-23_41f09e91-51cb-4225-ae79-1b5b19170322.html

Director's Dealing

Open in viewer

Opens in your device viewer

News Details

Directors’ Dealings | 23 July 2010 15:09

DGAP-DD: WILEX AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. —————————————————————————— Details of the person subject to the disclosure requirement Last name: Krebs First name: Andreas R. Position: Member of an administrative or supervisory body Information about the transaction with duty of notification Description of the financial instrument: Bearer shares of common stock ISIN/WKN of the financial instrument: DE0006614720 Type of transaction: Purchase Date: 20.07.2010 Price: 4.92 Currency: EUR No. of items: 1000 Total amount traded: 4920.00 Place: Frankfurt Information about the company with duty of publication Issuer: WILEX AG Grillparzerstr. 10 81675 München Deutschland ISIN: DE0006614720 WKN: 661472 End of Directors’ Dealings Notification (c) DGAP 23.07.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de ID 11666